Anm Pharma Private Limited
About Anm Pharma Private Limited
Data last updated:
Anm Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 24 December 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24233DL2013PTC262682. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹3 Cr and a paid-up capital of ₹2.31 Cr. It is led by directors including Anshul Sikri and Nidhi Arora.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 208 Okhla Industrial Estate Phase – III, New Delhi, Delhi, India – 110020.
As per the financials filed for FY 2025, the company reported a revenue of ₹190.81 Cr, a growth of 3% compared to the previous year. For the same year it recorded a net profit of ₹54.72 Lakh (net margin 0.3%) and EBITDA of ₹1.14 Cr (EBITDA margin 0.6%). Revenue has grown at a compounded annual rate (CAGR) of 1% over three years and 1% over five years.
The company has about 4 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Nishchem. As per MCA filings, the company has open charges of ₹65 Cr and satisfied charges of ₹50 Cr on record. Court records list 14 cases involving the company, including 8 filed by the company and 5 filed against it; 7 cases are pending. The company has 3 deals on record (1 rights issue, 1 funding round, 1 secondary share transfer), with disclosed funding of ₹6.6 Lakh; the latest was in October 2014. Its 10 peer companies in the Pharma industry (Pharma Retail and Distribution) are compared by revenue, 5 larger and 5 smaller; the largest is SMPL Life Sciences Private Limited with revenue of ₹194.66 Cr.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address208 Okhla Industrial Estate Phase – III, New Delhi, Delhi, India – 110020
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Anm Pharma Private Limited
The main business activity of Anm Pharma is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Anm Pharma Private Limited FY 2025 filings available
Anm Pharma Private Limited reported revenue of ₹190.81 Cr (up 3% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Anm Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 1% over five years, including 3% growth in the latest year. EBITDA fell 64% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Anm Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.14 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹54.72 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Anm Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.6% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.3% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Anm Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Anm Pharma Private Limited
Anm Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| SMPL Life Sciences Private Limited | ₹194.66 Cr (FY 2025) | •••• | •••• | 6.0% | •••• | New Delhi, Delhi, India |
| Sood Medicine Traders Private Limited | ₹194.03 Cr (FY 2025) | •••• | •••• | 7.0% | •••• | Punjab, India |
| Yogiram Distributors Private Limited | ₹193.7 Cr (FY 2025) | •••• | •••• | 44.0% | •••• | Cuddalore, Tamil Nadu, India |
| Chimanlal Sons Medicare Products Private Limited | ₹193.43 Cr (FY 2025) | •••• | •••• | 8.0% | •••• | Mumbai, Maharashtra, India |
| Livanova India Private Limited | ₹192.91 Cr (FY 2025) | •••• | •••• | 41.0% | •••• | Gurgaon, Haryana, India |
| Anm Pharma Private Limited this company | ₹190.81 Cr (FY 2025) | •••• | •••• | 3.0% | •••• | New Delhi, Delhi, India |
| Eris Oaknet Healthcare Private Limited | ₹188.94 Cr (FY 2021) | •••• | •••• | -3.0% | •••• | Ahmedabad, Gujarat, India |
| Kaushal Pharmaceuticals Private Limited | ₹186.1 Cr (FY 2025) | •••• | •••• | 13.0% | •••• | Kolkata, West Bengal, India |
| Pharmacare Logistics Private Limited | ₹185.02 Cr (FY 2025) | •••• | •••• | 8.0% | •••• | Mumbai, Maharashtra, India |
| Dadha Pharma Distribution Limited | ₹182.54 Cr (FY 2025) | •••• | •••• | -7.0% | •••• | Mumbai, Maharashtra, India |
| Mehta Medicare Pvt.Ltd. | ₹179.95 Cr (FY 2025) | •••• | •••• | -13.0% | •••• | Kolkata, West Bengal, India |
Peers are the five companies nearest above and the five nearest below Anm Pharma by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Anm Pharma Private Limited
Anm Pharma Private Limited is audited by BHAGI BHARDWAJ GAUR & CO. for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| BHAGI BHARDWAJ GAUR & CO. | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Anm Pharma Private Limited
Anm Pharma has 3 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anshul Sikri Also directs: Berg Healthcare LLP, Vaxer Pharma Limited | Director | 03 Feb 2014 | 12 Years 8 Months | Current |
| Nidhi Arora Also directs: Shevini Ventures LLP, Virmish Enterprises Private Limited, Arora Family Private Limited and 1 more | Director | 03 Feb 2014 | 12 Years 8 Months | Current |
| Bharat Balubhai Shah | Director | 03 Feb 2014 | 12 Years 8 Months | Current |
Ownership and Shareholding of Anm Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Anm Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Aug 2020 | Hdfc Bank Limited | ₹15 Cr | Open |
| 13 Feb 2014 | Yes Bank Limited | ₹50 Cr | Open |
| 02 Feb 2016 | Others | ₹50 Cr | Satisfied |
Total charge records: 3 View all charges
Deals & Funding of Anm Pharma Private Limited
Anm Pharma Private Limited has 3 deals on record (1 rights issue, 1 funding round, 1 secondary share transfer), with disclosed funding of ₹6.6 Lakh; the latest was in October 2014.
Deals on record (3 of 3)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Oct 2014 | Secondary share transfer | Undisclosed | Buyer: Mankind Pharma Limited Seller: 2 individuals |
| Apr 2014 | Rights issue | ₹2.24 Cr | Investors: Mankind Pharma Limited , Abs Mercantiles Private Limited , Nishchem International Private Limited |
| Mar 2014 | Funding round | ₹6.6 Lakh | Investors: Abs Mercantiles Private Limited , Nishchem International Private Limited |
Full deal history
All 3 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Anm Pharma Private Limited
Anm Pharma Private Limited has 14 court cases on record: 8 filed by Anm Pharma, 5 filed against it, 1 where it is another party. 7 cases are pending and 7 are disposed. Status as checked between 21 Sep 2026 and 02 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 7 | 5 | 2 |
| NCLAT | 4 | 0 | 4 |
| High courts | 3 | 0 | 1 |
Cases on record (5 of 14)
| Court | Type of case | Party | Status |
|---|---|---|---|
| NCLAT, New Delhi | Interim or miscellaneous application | Filed by the company against Centurion Laboratories Private Limited | Pending |
| NCLAT, New Delhi | Insolvency matter | Filed by the company against Centurion Laboratories Private Limited | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (SUMMARY CASE) | Filed by the company against Centurion Laboratories Private Limited | Pending |
| Bombay High Court | Writ petition | Company is another party | Pending |
| District court, Gurugram, Haryana | Court case (TRAFFIC) | Filed against the company by State of Haryana | Disposed |
Full case history
All 14 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Associated Brands with Anm Pharma Private Limited
Anm Pharma operates one associated brand: Nishchem. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures and distributes pharmaceutical APIs and formulations globally with import and export services. | nishchem.com |
Employees and EPFO Compliance at Anm Pharma Private Limited
Anm Pharma Private Limited has a workforce of 4 employees as of Mar 28, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Anm Pharma Private Limited
Anm Pharma Private Limited has 8 board changes on record since 2014: 3 appointments and 5 cessations. The latest: Bharat Balubhai Shah ceased to be Director on 01 Apr 2017.
6 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Anm Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Anm Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Anm Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Anm Pharma Private Limited
Anm Pharma has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Anm Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Anm Pharma Private Limited
Anm Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 24 December 2013 (13+ years old) and is registered under CIN U24233DL2013PTC262682.
Anm Pharma reported revenue of ₹190.81 Cr for FY 2025 (up 3% YoY).
Anm Pharma has 3 current directors:
- Anshul Sikri - Director
- Nidhi Arora - Director
- Bharat Balubhai Shah - Director
Anm Pharma reported a net profit of ₹54.72 Lakh (net margin 0.3%) and EBITDA of ₹1.14 Cr (EBITDA margin 0.6%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Anm Pharma is 1% over three years and 1% over five years. In the latest year (FY 2025) revenue rose 3%. CAGR is the steady yearly rate that links the first and the last year.
No. Anm Pharma has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Anm Pharma is U24233DL2013PTC262682. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Anm Pharma has 14 court cases on record: 8 filed by the company and 5 filed against it. 7 are pending. Most are in the district courts.
Anm Pharma was incorporated on 24 December 2013, making it 13+ years old. It is registered with the Registrar of Companies, Delhi.
Anm Pharma has 3 deals on record (1 rights issue, 1 funding round, 1 secondary share transfer), with disclosed funding of ₹6.6 Lakh; the latest was in October 2014.
The peers of Anm Pharma by revenue are SMPL Life Sciences Private Limited, Sood Medicine Traders Private Limited, Yogiram Distributors Private Limited, Chimanlal Sons Medicare Products Private Limited, Livanova India Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).